Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis

Journal of Investigative Dermatology

Volumn 118, Issue 4, 2002, Pages 728-733

  Nassif, Amal ^a   Bensussan, Armand ^a   Dorothée, Guillaume ^b   Mami Chouaib, Fathia ^b   Bachot, Nicolas ^a   Bagot, Martine ^a   Boumsell, Laurence ^a   Roujeau, Jean Claude ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cytotoxic; Drug hypersensitivity epidermal necrolysis; Toxic major histocompatibility complex T cell receptor T lymphocytes

Indexed keywords

BREFELDIN A; CD56 ANTIGEN; CD8 ANTIGEN; CONCANAMYCIN A; COTRIMOXAZOLE; DRUG METABOLITE; EGTAZIC ACID; FAS ANTIBODY; HLA DR ANTIGEN; IMMUNOGLOBULIN; KETOPROFEN; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY; OMEPRAZOLE; SULFAMETHOXAZOLE; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; ARTICLE; BETA CHAIN; BULLOUS SKIN DISEASE; CASE REPORT; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG HYPERSENSITIVITY; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATITIS; SKIN DEFECT; TOXIC EPIDERMAL NECROLYSIS;

EID: 0036230022     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.01622.x     Document Type: Article

References (21)

1. Toxic epidermal necrolysis
2. Wilkinson DI, Carlo DJ. CD8 + T-cells in psoriasis lesions preferentially use T-cell receptors Vβ 3 and/or Vβ 13.1 genes
3. Cutaneous T-cell recruitment in toxic epidermal necrolysis, further evidence of CD8+ lymphocyte involvement
4. Dominant T-cell-receptor beta chain variable Vβ 14+ clones in juvenile rheumatoid arthritis
5. CD8+ dermal T-cells from a sulfamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes
6. Idiosyncratic drug reactions: The reactive metabolite syndromes
7. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors
8. Anticonvulsant-induced toxic epidermal necrolysis: Monitoring the immunologic response
9. Toxic epidermal necrolysis (the scalded skin syndrome): A reappraisal
10. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfamethoxazole, phenytoin and carbamazepine
11. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis
12. Cytolytic effector function in human circulating CD8+ T cells correlates with CD56 surface expression
13. Severe cutaneous adverse reactions to drugs
14. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
15. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones
16. T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction
17. Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals
18. Clonal transformation of adult human leukocytes by Epstein-Barr virus
19. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
20. T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic
21. The HLA-A, B "negative" mutant cell line C1R expresses a HLA-B35 allele, which also has a point mutation in the trans initiation codon